The Neuromod Prize is a SPARC (Stimulating Peripheral Activity to Relieve Conditions) initiative from the National Institutes of Health (NIH) Common Fund. The competition seeks groundbreaking uses of peripheral nerve stimulation that can independently regulate two or more desired autonomic functions without unintended effects on non-target organs. At the discretion of NIH, additional competition phases may follow Phase 1.

Learn more about the Neuromod Prize by attending a virtual information session on February 7. The National Institutes of Health (NIH) team will give an in-depth overview of the competition and answer questions.

More about the $9.8 million competition

The Neuromod Prize is a SPARC (Stimulating Peripheral Activity to Relieve Conditions) initiative from NIH that is accelerating the development of targeted neuromodulation therapies. The first phase calls on scientists, engineers, and clinicians to submit novel concepts and plans for development.

The competition is open to U.S. entrants, subject to eligibility requirements. Phase 1 entrants will submit concept papers describing their proposed therapeutic approaches, their plans for conducting proof-of-concept studies, their rationales for therapeutic use, and their expectations for clinical impact. Submissions are due by 4:59 p.m. EDT on April 28.

Explore the Neuromod Prize resource hub to learn more about present and emerging methods for bioelectronic medicine, research tools, clinical translation, and target performance considerations.